Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1143 result(s) found, displaying 476 to 500

  • AusPAR: Osimertinib mesilate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Osimertinib mesilate

  • AusPAR: Erenumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Erenumab

  • AusPAR: Tiotropium bromide

    Australian public assessment report (AusPar)
    Australian public assessment report for Tiotropium bromide

  • AusPAR: Inotuzumab ozogamicin

    Australian public assessment report (AusPar)
    Australian Public Assessment for Inotuzumab ozogamicin

  • AusPAR: Denosumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Denosumab

  • AusPAR: Pegfilgrastim

    Australian public assessment report (AusPar)
    Australian Public Assessment for Pegfilgrastim

  • AusPAR: Liraglutide

    Australian public assessment report (AusPar)
    Australian Public Assessment for Liraglutide

  • AusPAR: Baricitinib

    Australian public assessment report (AusPar)
    Australian Public Assessment for Baricitinib

  • AusPAR: Plitidepsin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Plitidepsin

  • AusPAR: Lenalidomide

    Australian public assessment report (AusPar)
    Australian Public Assessment for Lenalidomide

  • AusPAR: Octocog alfa (bhk)

    Australian public assessment report (AusPar)
    Australian Public Assessment for Octocog alfa (bhk)

  • AusPAR: Sarilumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment for Sarilumab (rch)

  • AusPAR: Regorafenib

    Australian public assessment report (AusPar)
    Australian Public Assessment for Regorafenib

  • AusPAR: Rufinamide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Rufinamide

  • AusPAR: Safinamide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Safinamide

  • AusPAR: Benralizumab

    Australian public assessment report (AusPar)
    Australian Public Assessment for Benralizumab

  • AusPAR: Adalimumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Adalimumab

  • AusPAR: Olaparib

    Australian public assessment report (AusPar)
    Australian Public Assessment for Olaparib

  • AusPAR: Avelumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Avelumab